Skip to main content

Table 1 Clinical characteristics

From: microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer

Features

Cervical cancer, N (%)

Normal, N (%)

Total, n (%)

66 (100.0)

50 (100.0)

Age

  < 45 years

20 (30.3)

20 (40.0)

  ≥ 45 years

46 (69.7)

30 (60.0)

Histological type

 ADC

7 (10.6)

 

 SCC

59 (89.4)

 

Tumor size

  < 4 cm

30 (45.5)

 

  ≥ 4 cm

36 (54.5)

 

FIGO stage

 IA-IIA

29 (43.9)

 

 IIB-IVB

37 (56.1)

 

Lymph node metastasis

 No

35 (53.0)

 

 Yes

31 (47.0)

 

HPV E6/E7 expression

 Negative

12 (18.2)

 

 Positive

54 (81.8)

 

Survival

 Alive

52 (78.8)

 

 Died

14 (21.2)

 
  1. Abbreviations: FIGO International Federation of Gynecology